Meso Numismatics, Inc. engages in the numismatic business in the United States and internationally. The company sells coins, paper currency, bullion, and medals through live auctions. It also offers banknote scanner, an application to identify key characteristics of a banknote; and sells its products through an online store, mesocoins.com. In addition, the company provides CELLGENIC FLOW EXOSOMES; CELLGENIC MSC, which excretes growth factors, cytokines, and proteins for regeneration of tissue; CELLGENIC LUMA that is derived from human umbilical cord mesenchymal stem cells, including potent growth factors, peptides, coenzymes, minerals, amino acids, vitamins, and UV radiation reducing agents for skin revitalization; VITANOVAS that offers in-home treatments to patients in need of immune modulation to help fight infections, viruses, and diseases; GCELL RESTORE, a closed-system medical device to harness the natural and restorative capabilities of adipose tissue; CELLGENIC SVF, an isolation kit system that has the ingredients and consumables for the extraction of adipose-derived stem cells from fat; CELLGENIC BONE MARROW; and CELLGENIC Platelet Rich Plasma for healing and reducing inflammation. Further, it offers training services to doctors. The company was formerly known as Pure Hospitality Solutions, Inc. and changed its name to Meso Numismatics, Inc. in September 2018. Meso Numismatics, Inc. was founded in 1999 and is based in Boca Raton, Florida.
What is Regenerative Medical Technology Group stock price today?▼
The current price of MSSV is $0.04 USD — it has decreased by -24.07% in the past 24 hours. Watch Regenerative Medical Technology Group stock price performance more closely on the chart.
What is Regenerative Medical Technology Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Regenerative Medical Technology Group stocks are traded under the ticker MSSV.
What were Regenerative Medical Technology Group earnings last quarter?▼
MSSV earnings for the last quarter are -0.11 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Regenerative Medical Technology Group revenue for the last year?▼
Regenerative Medical Technology Group revenue for the last year amounts to 2.41M USD.
What is Regenerative Medical Technology Group net income for the last year?▼
MSSV net income for the last year is -9.81M USD.
How many employees does Regenerative Medical Technology Group have?▼
As of April 01, 2026, the company has 1 employees.
In which sector is Regenerative Medical Technology Group located?▼
Regenerative Medical Technology Group operates in the Consumer Discretionary sector.
When did Regenerative Medical Technology Group complete a stock split?▼
Regenerative Medical Technology Group has not had any recent stock splits.
Where is Regenerative Medical Technology Group headquartered?▼
Regenerative Medical Technology Group is headquartered in Boca Raton, US.